• 1
    Cox P, Marton T. Pathological assessment of intrauterine growth restriction. Best Pract Res Clin Obstet Gynaecol 2009; 23: 75164.
  • 2
    Wu O, Bayoumi N, Vickers M, Clark P. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 2008; 6: 629.
  • 3
    Clark P, Wu O. ABO blood groups and thrombosis: a causal association, but is there value in screening? Future Cardiol 2011; 7: 191201.
  • 4
    Djousse L, Karamohamed S, Herbert A, D’Agostino R, Cupples L, Ellison R. Fucosyltransferase 3 polymorphism and atherothrombotic disease in the Framingham Offspring Study. Am Heart J 2007; 153: 6369.
  • 5
    Hein HO, Suadicani P, Gyntelberg F. Lewis phenotypes, leisure time physical activity, and the risk of ischaemic heart disease: an 11 year follow up in the Copenhagen male study. Heart 2001; 85: 15964.
  • 6
    Hein S, Sorensen H, Saudicani P, Gyntelberg F. The Lewis blood group – a new genetic marker of ischaemic heart disease. J Intern Med 1992; 232: 4818.
  • 7
    Ellison R, Zhang Y, Myers R, Swanson J, Higgins M, Eckfeldt J. Lewis blood group phenotype as an independent risk factor for coronary heart disease (The NHLBI Family Heart Study). Am J Cardiol 1999; 83: 3458.
  • 8
    Clausen JO, Hein HO, Suadicani P, Winther K, Gyntelberg F, Pedersen O. Lewis phenotypes and the insulin resistance syndrome in young healthy white men and women. Am J Hypertens 1995; 8: 10606.
  • 9
    Saha N, Toh C, Ghosh M. Genetic association in myocardial infarction. Ethnicity, ABO, Rh, Le (a), Xg (a) blood groups, G6PD deficiency and abnormal haemoglobins. J Med Genet 1973; 10: 3405.
  • 10
    Clark P, Meiklejohn DJ, O’Sullivan A, Vickers MA, Greaves MJ. The relationships of ABO, Lewis and Secretor blood groups with cerebral ischaemia of arterial origin. J Thromb Haemost 2005; 3: 21058.
  • 11
    Orstavik K, Kornstad L, Reisner H, Berg K. Possible effect of secretor locus on plasma concentration of factor VIII and von Willebrand factor. Blood 1989; 73: 9903.
  • 12
    Schleef M, Erwin S, Dick A, Frank J, Schramm W, Spannagl M. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals. Br J Haematol 2005; 128: 1007.
  • 13
    Green D, Jarrett O, Ruth KJ, Folsom AR, Liu K. Relationship among Lewis phenotype, clotting factors, and other cardiovascular risk factors in young adults. J Lab Clin Med 1995; 125: 3349.
  • 14
    Cakir B, Heiss G, Pankow J, Salomaa V, Sharrett A, Couper D, Weston BW. Association of the Lewis genotype with cardiovascular risk factors and subclinical carotid atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) study. J Intern Med 2004; 255: 4051.
  • 15
    Foxall C, Waltson S, Dowbenko D, Fennie C, Lasky L, Kiso M, Haseqawa A, As D, Brandly BK. The three members of the selectin receptor family recognize a common carbohydrate epitope, the sialyl Lewis (x) oligosaccharide. J Cell Biol 1992; 117: 895902.
  • 16
    Sheu B, Sheu S, Yang H, Huang A, Wu J. Host gastric Lewis expression determines the bacterial density of Helicobacter pylori in babA2 genopositive infection. Gut 2003; 52: 92732.
  • 17
    Minas V, Mylonas I, Scgiessl B, Mayr D, Schulze S, Friese K, Jeschke U, Makrigiannakis A. Expression of the blood-group-related antigens sialyl Lewis a, sialyl Lewis X and Lewis Y in term placentas of normal, preeclampsia, IUGR- and HELLP-complicated pregnancies. Histochem Cell Biol 2007; 128: 5563.
  • 18
    Clark P, Walker I, Govan L, Wu O, Greer I. The GOAL study: a prospective examination of the impact of factor V Leiden and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes. Br J Haematol 2008; 140: 23640.
  • 19
    Clark P, Sattar N, Walker ID, Greer IA. The Glasgow outcome, APCR and lipid (GOAL) Pregnancy Study: significance of pregnancy associated activated protein C resistance. Thromb Haemost 2001; 85: 305.
  • 20
    Altman D, Coles E. Normograms for precise determination of birth weight for dates. Br J Obstet Gynaecol 1980; 87: 816.
  • 21
    Clark P, O’Sullivan A, Forgan M, Campbell DM, Greaves M, Walker ID, Greer IA, Vickers MA. ABO and secretor genotypes and the risk of pre-eclampsia. J Thromb Haemost 2005; 3(Suppl. 1): P0493.
  • 22
    Downing J, Darke C. A modified PCR-SSP method for the identification of ABO blood group antigens. Eur J Immunogen 2003; 30: 2958.
  • 23
    O’Donnell J, Boulton F, Manning R, Laffan M. Genotype at the secretor blood locus is a determinant of plasma von Willebrand factor level. Br J Haematol 2002; 116: 3506.
  • 24
    Vestergaard E, Wolf H, Orntoft T. Increased concentration of genotype-interpreted Ca 19-9 in urine of bladder cancer patients mark diffuse atypia of the urothelium. Clin Chem 1998; 44: 197204.
  • 25
    Clark P, Walker ID. The phenomenon known as acquired activated protein C resistance. Br J Haematol 2001; 115: 18.
  • 26
    Clark P, Brennand J, Conkie JA, McCall F, Greer IA, Walker ID. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998; 79: 116670.
  • 27
    Pell J, Smith G, Dominiczak A, Cobbe S, Dobbie R, McMahon A, Ford I. Family history of premature death from ischaemic heart disease is associated with an increased risk of delivering a low birth weight baby. Heart 2003; 89: 124950.
  • 28
    Barker D, Osmond C, Golding J, Kuh D, Wadsorth M. Growth in utero, blood pressure in childhood and adult life and mortality from cardiovascular disease. Br Med J 1989; 298: 5647.
  • 29
    Pell J, Smith G, Walsh D. Pregnancy complications and subsequent maternal cerebrovascular events: a retrospective cohort study of 119,668 births. Am J Epidemiol 2004; 159: 33642.
  • 30
    Berends A, de Groot C, Sijbrands E, Sie M, Benneheij S, Pal R, Hydanus R, Oostra BA, van Duijn CM, Steegers EAP. Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease. Hypertension 2008; 51: 103441.
  • 31
    Smith G, Harding S, Rosato M. Relation between infant’s birth weight and mother’s mortality: prospective observational study. Br Med J 2000; 320: 83940.
  • 32
    Langman M, Elwood P, Goote J, Ryrie D. ABO and Lewis blood groups and serum cholesterol. Lancet 1969; 2: 6079.
  • 33
    Wakely E, Langman MJ, Elwood P. Blood group A sub-groups and serum cholesterol. Cardiovasc Res 1973; 7: 67983.
  • 34
    Hall R, Bunch G, Humphrey C. The frequencies of ABO blood groups and secretors of ABH substances in peripheral atherosclerosis. Atheroscler 1971; 14: 2416.
  • 35
    Clark P, Walker I, Greer I. Acquired activated protein-C resistance in pregnancy and association with increased thrombin generation and fetal weight. Lancet 1999; 353: 2923.
  • 36
    Witsenburg C, Rosendaal F, Middeldorp J, van der Meer F, Scherjon S. Factor VIII levels and the risk of pre-eclampsia, HELLP syndrome, pregnancy related hypertension and severe intrauterine growth restriction. Thromb Res 2005; 115: 38792.